Original Research

A multicenter evaluation of the efficacy and duration of action of alcaftadine 0.25% and olopatadine 0.2% in the conjunctival allergen challenge model

Ackerman S, D'Ambrosio, Jr F, Greiner JV, Villanueva L, Ciolino JB, Hollander DA

Journal of Asthma and Allergy 2013, 6:43-52

Published Date: 8 April 2013